Search research articles
Contact Us
Filters
Showing results (231-240 of 352) with videos related to
Page
of 36
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1978
Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm
J S Macdonald, M E Lippman, P V Woolley, et al.
Endocrinology
|
October 1, 1996
Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines
M Saceda, T W Grunt, R Colomer, et al.
Breast Cancer Research and Treatment
|
March 1, 1995
Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies
J Ruiz-Cabello, K Berghmans, O Kaplan, et al.
Cancer Research
|
October 28, 1999
Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo
C K Tang, X Z Concepcion, M Milan, et al.
Molecular Endocrinology (Baltimore, Md.)
|
January 1, 1992
Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression
K J Cullen, M E Lippman, D Chow, et al.
Journal of the National Cancer Institute
|
February 1, 1982
Vasopressin: action on WRK-1 rat mammary tumor cells
M E Monaco, P H Kohn, W R Kidwell, et al.
Cancer Treatment and Research
|
January 1, 1996
Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms
R Clarke, T Skaar, F Leonessa, et al.
FEBS Letters
|
July 3, 1989
Transformation of mouse mammary epithelial cells with the Ha-ras but not with the neu oncogene results in a gene dosage-dependent increase in transforming growth factor-alpha production
F Ciardiello, N Hynes, N Kim, et al.
Cancer Research
|
June 13, 2000
Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer
C K Tang, X Q Gong, D K Moscatello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)
N Brünner, D Yee, F G Kern, et al.
Page
of 36
Search research articles
Search
Showing results (231-240 of 352) with videos related to
Sort By:
Page
of 36
Cancer Chemotherapy and Pharmacology
|
January 1, 1978
Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm
J S Macdonald, M E Lippman, P V Woolley, et al.
Endocrinology
|
October 1, 1996
Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines
M Saceda, T W Grunt, R Colomer, et al.
Breast Cancer Research and Treatment
|
March 1, 1995
Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies
J Ruiz-Cabello, K Berghmans, O Kaplan, et al.
Cancer Research
|
October 28, 1999
Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo
C K Tang, X Z Concepcion, M Milan, et al.
Molecular Endocrinology (Baltimore, Md.)
|
January 1, 1992
Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression
K J Cullen, M E Lippman, D Chow, et al.
Journal of the National Cancer Institute
|
February 1, 1982
Vasopressin: action on WRK-1 rat mammary tumor cells
M E Monaco, P H Kohn, W R Kidwell, et al.
Cancer Treatment and Research
|
January 1, 1996
Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms
R Clarke, T Skaar, F Leonessa, et al.
FEBS Letters
|
July 3, 1989
Transformation of mouse mammary epithelial cells with the Ha-ras but not with the neu oncogene results in a gene dosage-dependent increase in transforming growth factor-alpha production
F Ciardiello, N Hynes, N Kim, et al.
Cancer Research
|
June 13, 2000
Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer
C K Tang, X Q Gong, D K Moscatello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)
N Brünner, D Yee, F G Kern, et al.
Page
of 36